The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 13, Pages 1714-1723
Publisher
Springer Nature
Online
2012-05-14
DOI
10.1038/onc.2012.179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
- (2015) Wolfgang Hagmann et al. NEOPLASIA
- The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways
- (2012) Nicolas Jonckheere et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells
- (2011) Y. D. Bhutia et al. CANCER RESEARCH
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma
- (2010) Raphaël Maréchal et al. CANCER
- Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
- (2010) Shuang-Jia Wang et al. CANCER LETTERS
- The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
- (2010) Lars Petter Jordheim et al. LANCET ONCOLOGY
- MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells
- (2010) M P Ponnusamy et al. ONCOGENE
- Mucins and Pancreatic Cancer
- (2010) Nicolas Jonckheere et al. Cancers
- Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy
- (2009) Dirk Theile et al. BIOCHEMICAL PHARMACOLOGY
- Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
- (2009) S Bafna et al. BRITISH JOURNAL OF CANCER
- Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression
- (2009) N Jonckheere et al. BRITISH JOURNAL OF CANCER
- Downregulation of nuclear factor-κB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer
- (2009) Rui Kong et al. CANCER LETTERS
- The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms
- (2009) H. C. Workman et al. CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
- (2009) R. Marechal et al. CLINICAL CANCER RESEARCH
- Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours
- (2008) Ashish V. Kalra et al. EUROPEAN JOURNAL OF CANCER
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started